FilingSEC EDGAR6-K
Galmed Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
· SEC accepted
StageRegained Compliance
Filing content
Galmed Pharmaceuticals announced that it has regained compliance with the Nasdaq minimum bid price requirement and is now in compliance with all applicable listing standards.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…